SA Health Minister's ARV program backed

1 October 2006

South African Health Minister Manto Tshabalala-Msimang, who has been the target of foreign-led calls for her resignation (Marketletter September 4), received an endorsement from the Washington DC, USA-based think-tank, the Hudson Institute.

Jeremiah Norris, the Institute's center for science in public policy director, writing in the South African Business Day newspaper described the criticism as based on unsustainable World Health Organization targets, including the failed "3 by 5" campaign to put three million people worldwide on antiretroviral drugs by 2005. Instead, he claims, the South African government has taken a "tortoise-like" approach by the end of 2005 the country was treating 99,000 patients, rising to about 140,000 at present.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight